Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novo Nordisk A/S (NVO) vs Riot Platforms Inc (RIOT) Price & Performance

Novo Nordisk A/STrade
Riot Platforms IncTrade

Price performance (Past 24H)

Key statistics

Novo Nordisk A/S vs Riot Platforms Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Riot Platforms Inc trades at $21.48 (market cap $7.53B). The key difference: Novo Nordisk A/S is far larger — about 29.3× Riot Platforms Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Riot Platforms Inc pays none. Which is the better fit depends on your goals.

NVORIOT
Market Cap
$220.53B$7.53B
Sector
HealthTechnology
52-Week High
$71.70$28.67
52-Week Low
$35.29$11.03
Enterprise Value
$239.49B$8.20B
Dividend Yield
3.63%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Read more on NVO

About Riot Platforms Inc

Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.

Read more on RIOT